✦ LIBER ✦

GP IIb/IIIa inhibitors during primary percutaneous coronary intervention for STEMI: New trial and registry data

✍ Scribed by Umesh U. Tamhane; Hitinder S. Gurm

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TCT-366: Prognostic Role of Thrombus Asp

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 70 KB

The REPLACE 1 trial: a pilot study of bi

✍ A.Michael Lincoff; John A. Bittl; Neal S. Kleiman; Dean J. Kereiakes; Robert A. 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 336 KB

Cost analysis of bivalirudin versus refe

✍ Puymirat, E.; Cohen, S.; Védrenne, G.; Caruba, T.; Sabatier, B.; Danchin, N.; Du 📂 Article 📅 2013 🏛 Elsevier Science 🌐 French ⚖ 287 KB

Effectiveness of Glycoprotein IIb/IIIa I

✍ Vankeepuram S. Srinivas; Basel Skeif; Abdissa Negassa; Ji Yon Bang; Hussein Shaq 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Primary percutaneous coronary interventi

✍ Michael Mok; Alexander J. Black; Andrew E. Ajani; Stephen J. Duffy; Nick Adriano 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Association of glycoprotein IIb/IIIa inh

✍ Jeffrey S. Berger; David L. Brown 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 210 KB